Oncoclínicas do Brasil Serviços Médicos S.A.
B3:ONCO3.SA
6.2 (BRL) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) BRL.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 5,488.776 | 4,088.252 | 2,702.066 | 2,035.191 | 1,689.51 | 1,050.836 | 791.837 | 594.811 | 457.971 | 359.453 | 269.135 |
| Cost of Revenue
| 3,560.2 | 2,636.145 | 1,833.275 | 1,399.514 | 1,228.981 | 741.43 | 480.256 | 359.063 | 263.491 | 214.295 | 130.307 |
| Gross Profit
| 1,928.576 | 1,452.107 | 868.791 | 635.677 | 460.529 | 309.406 | 311.581 | 235.748 | 194.48 | 145.158 | 138.828 |
| Gross Profit Ratio
| 0.351 | 0.355 | 0.322 | 0.312 | 0.273 | 0.294 | 0.393 | 0.396 | 0.425 | 0.404 | 0.516 |
| Reseach & Development Expenses
| 0.037 | 0 | 0 | 0 | 0 | 0.249 | 0.547 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 1,172.069 | 980.817 | 688.05 | 603.609 | 340.727 | 221.298 | 226.821 | 179.614 | 135.437 | 113.987 | 60.338 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1,172.069 | 980.817 | 688.05 | 603.609 | 340.727 | 221.298 | 226.821 | 179.614 | 135.437 | 113.987 | 60.338 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 1,172.069 | 981.007 | 691.576 | 616.061 | 338.774 | 237.68 | 243.931 | 196.515 | 149.479 | 117.904 | 70.145 |
| Operating Income
| 756.507 | 470.565 | 177.215 | 19.616 | 121.755 | 82.74 | 42.829 | 42.192 | 41.117 | 18.368 | 79.078 |
| Operating Income Ratio
| 0.138 | 0.115 | 0.066 | 0.01 | 0.072 | 0.079 | 0.054 | 0.071 | 0.09 | 0.051 | 0.294 |
| Total Other Income Expenses Net
| -442.342 | -349.025 | -114.878 | -76.734 | -41.386 | -28.971 | 17.944 | -23.866 | -24.537 | -8.768 | -18.419 |
| Income Before Tax
| 314.165 | 121.54 | 62.337 | -57.118 | 80.369 | 53.769 | 60.773 | 18.326 | 16.58 | 9.6 | 60.659 |
| Income Before Tax Ratio
| 0.057 | 0.03 | 0.023 | -0.028 | 0.048 | 0.051 | 0.077 | 0.031 | 0.036 | 0.027 | 0.225 |
| Income Tax Expense
| -10.044 | 7.77 | 84.754 | 68.087 | 61.273 | 37.512 | 25.391 | 19.247 | 19.156 | 16.638 | 21.152 |
| Net Income
| 223.618 | 46.26 | -46.9 | -159.619 | -20.417 | -17.078 | 3.145 | -25.358 | -24.768 | -22.165 | 20.504 |
| Net Income Ratio
| 0.041 | 0.011 | -0.017 | -0.078 | -0.012 | -0.016 | 0.004 | -0.043 | -0.054 | -0.062 | 0.076 |
| EPS
| 0.43 | 0.096 | -0.099 | -39.41 | -5.1 | -0.048 | 0 | -0.11 | -0.14 | -1.02 | 0 |
| EPS Diluted
| 0.42 | 0.087 | -0.099 | -39.41 | -5.1 | -0.048 | 0 | -0.11 | -0.14 | -1.02 | 0 |
| EBITDA
| 1,013.872 | 707.92 | 340.399 | 120.872 | 186.079 | 98.388 | 54.434 | 55.683 | 49.507 | 23.924 | 80.164 |
| EBITDA Ratio
| 0.185 | 0.173 | 0.126 | 0.059 | 0.11 | 0.094 | 0.069 | 0.094 | 0.108 | 0.067 | 0.298 |